Published December 15, 2025 | Version v1
Journal article Open

REVIEW ON MODERN PROGRESS IN PHARMACY PRACTICE: EXPLORING FUTURE DIRECTIONS

Authors/Creators

  • 1. Fabtech College of Pharmacy, Sangola-413307 District- Solapur, Maharashtra.

Description

This review examines the variables that could affect practice going forward. Three levels of transformation are possible. First of all, the pharmacist's conventional role as a medication dispenser is growing. Second, the pharmacist's work is expanding into new areas of medicine. Thirdly, happenings around the world spur other adjustments. Leaders in pharmacy and healthcare who are considering the future structure and objectives of their pharmacy services may find this review useful. The rise in chronic illnesses, changes in the global population, and technological advancements are all placing a great deal of strain on healthcare. In line with this, pharmacies are evolving from traditional drug distributors to also playing a more sophisticated clinical role. The purpose of this study was to ascertain what the research agenda for pharmacy practice would include from the perspectives of pharmacy practitioners and scholars in five high-income nations.

Files

20 WJPSR 1871.pdf

Files (550.7 kB)

Name Size Download all
md5:62279f6266458cda4730e29758fd921a
550.7 kB Preview Download

Additional details

References

  • 1. Al Kuwaiti A, Nazer K, Al-Reedy A, et al. A review of the role of artificial intelligence in healthcare. J Pers Med., 2023; 13(6): 951.-955
  • 2. Martiz-Millana A, Saez-Saez A, Tornero-Costa R, Azzopardi-Muscat N, Traver V, NovilloOrtiz D. Artificial intelligence and its impact on the domains of universal health coverage, health emergencies and health promotion: an overview of systematic reviews. Int J Med Inform, 2022; 16 (6): 104-855.
  • 3. Gala D, Behl H, Shah M, Makaryus AN. The role of artificial intelligence in improving patient outcomes and future of healthcare delivery in cardiology: a narrative review of the literature. Healthcare, 2022; 4(18): 77-79
  • 4. Khan O, Parvez M, Kumari P, Parvez S, Ahmad S. The future of pharmacy: how AI is revolutionizing the industry. Intelligent Pharm, 2023; 1(1): 32–40.
  • 5. Ranchon F, Chanoine S, Lambert-Lacroix S, Bosson JL, Moreau-Gaudry A, Bedouch P. Development of artificial intelligence powered apps and tools for clinical pharmacy services: a systematic review. Int J Med Inform, 2023; 172(4): 104983.
  • 6. Grothen AE, Tennant B, Wang C, et al. Application of artificial intelligence methods to pharmacy data for cancer surveillance and epidemiology research: a systematic review. JCO Clin Cancer Inform, 2020; 4(4): 1051–1058.
  • 7. Liu X, Barreto EF, Dong Y, et al. Discrepancy between perceptions and acceptance of clinical decision support Systems: implementation of artificial intelligence for vancomycin dosing. BMC Med Inform Decis Mak, 2023; 23(1): 157.
  • 8. Cortes D, Leung J, Ryl A, Lieu J. Pharmacy informatics: where medication use and technology meet. Can J Hosp Pharm, 2019; 72(4): 320–326.
  • 9. Shanbhogue MH, Thirumaleshwar S, Tegginamath PK, Somareddy HK. Artificial intelligence in pharmaceutical field - a critical review. Curr Drug Deliv, 2021; 18(10): 1456– 1466.
  • 10. Faure, o.Le medicament France au XIXe siècle. Un triomphe inattendu. Bull Dhistoire Depistemologie Sci, 2024; 21: 119-130.
  • 11. Holloway, S.W.F. The apothecaries act, A reinterpretation. Med. Hist, 1966; 10: 107-129.
  • 12. Royal Pharmaceutical Society, UK. Early History and Foundation, 1922; 45(2): 120.
  • 13. Anderson, S.The state of the world's pharmacy. A portrait of the pharmacy profession. Journal of Interprofessional Care, 2005; (19)4: 349-356.
  • 14. World Health Organization. The role of the pharmacist in the health care system. WHO/PHARM. World Health Organization, 2009; (4): 97,599.
  • 15. Wiedenmayer, K.Summers, R.S. Mackie, C.A., Gous, A.G.S., Everard, M., &Tromp, D. Developing pharmacy practice: A focus on patient care. World Health Organization & International Pharmaceutical Federation, 2006; (12): 78-80
  • 16. Smith, M. C. pharmacy practice: A guide to the profession. Williams &Wilkins, 2002; 112.
  • 17. Atkinson, J. Competences for Pharmacy Education and Practice in Europe. In Pharmacy; Multidisciplinary Digital Publishing Institute: Basel, Switzerland, 2018; 34: 112-118.
  • 18. Andrews, L.Ralston, S.Blomme, E.Barnhart, k.A snapshot of biologic drug development. Hum. Exp. Toxicol, 2026; 34: 67-80
  • 19. Ritter, J. M. ;Flower,R.; Henderson,G.; Loke, Y. K.; Rang, H. P Rang and Dale's Pharmacology(Chapter 5 how drugs Act: Biopharmaceuticals and Gene Therapy) Elsevier:London, UK, 2020; 152: 80-85.
  • 20. Chen, Y; Monnard, A; Santos da Silva, J. An Inflection Point for Biosimilars Mackinsey Life Sciences: New York, NY, USA, 2021; 27: 76-89.
  • 21. LEEM: Les Entreprises Medicament. Santé, analysis Prospective de L'innovation Santé, 2021; 64: 67-78.
  • 22. Guy, J.W; Patel, l; Oestreich, J.clinical application and Educational Training for pharmacogenomics. Pharmacy, 2020; 8(163).
  • 23. Reizine, N.M, O'Donnell, P.H.Modern development in germline pharmacogenomics for on cology prescribing. CA Cancer J. Clin, 2022; 72: 315-332.
  • 24. Pardinas, A.F; Owen, M. J.; walters, J.T.Pharmacogenomics: road ahead for precision medicine in psychiatry. Neuron, 2021; 109: 3914-3929.
  • 25. Ganguly,N.K;Saha,G.K.Pharmacogenomics and Personalized Medicine for infectious diseases.In Omics for Personalized Medicine; Barh, D; Dhawan, D; Ganguly, N, Eds; Springer: New Delhi, India, 2025; 603-635.
  • 26. Zhou, Z. Phrmacogenomics in cardiovascular precision medicine. J. Lab. Precis. Med, 2020; 5: 30.
  • 27. Gidley, S.; Scott-Thomas, S.; Anderson, C.; Burton, J. The Future of Pharmacy in Gidley, S.; Scott-Thomas, S.; Anderson, C.; Burton, J. The Future of Pharmacy in a Sustainable NHS: Key Principles for Transformation and Growth. Royal Pharmaceutical Society, 2020; 1-25.
  • 28. LEEM: Les Entreprises du Médicament. Santé 2030, une Analyse Prospective de L'innovation en Santé, 2021; 64: 67-89.
  • 29. Hodkinson, A.; Tyler, N.; Ashcroft, D.M.; Keers, R.N.; Khan, K.; Phipps, D.; Abuzour, A.; Bower, P.; Avery, A.; Campbell, S; Preventable medication harm across health care settings. A. Systematic reviews and meta-analysis. BMC Med., 2020; 18: 313.
  • 30. Beks, H.; Mc Namara, K.; Manias, E.; Dalton, A.; Tong, E.; Dooley, M. Hospital pharmacists' experiences of participating in a Partnered Pharmacist Medication Charting credentialing program:A qualitative study. BMC health services. Res., 2020; 21: 73.
  • 31. California State Board of Pharmacy. (Cal. Code Regs. Tit. 16, § 1746.3) Protocol for Pharmacists Furnishing Naloxone Hydrochloride, 2022: 1-5.
  • 32. Puzantian, T.; Gasper, J.J. Provision of naloxone without a prescription by California pharmacists 2 years after legislation implementation. JAMA, 2018; 320: 1933-1934.
  • 33. Cope, L.C.; Abuzour, A.S.; Tully, M. Nonmedical prescribing: Where are we now? Ther. Adv. Drug Saf., 2016; 7: 165–172.
  • 34. Stone, R.H.; Rafie, S.; Ernest, D.; Scutt, B. Emergency Contraception Access and Counseling in Urban Pharmacies: A Comparison between States with and without Pharmacist Prescribing. Pharmacy, 2020; 8: 105.
  • 35. Marston, H.D.; Dixon, D.M.; Knisely, J.M.; Palmore, T.N.; Fauci, A.S. Antimicrobial Resistance. JAMA J. Am. Med. Assoc, 2016; 316: 1193-1204.
  • 36. Liaskou, M.; Duggan, C.; Joynes, R.; Rosado, H. Pharmacy's Role in Antimicrobial Resistance and Stewardship, 2018: 1-20.
  • 37. Llor, C.; Bjerrum, L. Antimicrobial resistance: Risk associated with antibiotic overuse and initiatives to reduce the problem. There Adv Drug Saf., 2014; 5: 229-241.
  • 38. Tan, E.C.; Stewart, K.; Elliott, R.A.; George, J. Pharmacist services provided in general practice clinics: A systematic review and meta-analysis. Res.soc. Adm.pharm, 2014; 10: 608-622.
  • 39. Thomson, K.; Hillier-Brown, F.; Walton, N.; Bilaj, M.; Bambra, C.; Todd, A. The effects of community pharmacy-delivered public health interventions on population health and health inequalities: A review of reviews.Prev.Med., 2019; 124: 98-109.
  • 40. Hilts, K.E.; Corelli, R.L.; Prokhorov, A.V.; Zbikowski, S.M.; Zillich, A.J.; Hudmon, K.S. Implementing Brief Tobacco Cessation Interventions in Community pharmacies: An application of Roger's Diffusion of Innovation Theory. Pharmacy, 2022; 10: 56.
  • 41. Brown, T.J.; Todd, A.; O'Malley, C.; Moore, H.; Husband, A.; Bambra, C.; Kasim, A.S.; Sniehotta, F.; Steed, L.; Smith, S.; Community Pharmacy-delivered interventions for public health priorities: A systematic review of interventions for alcohol reduction, smoking cessation and weight management, including meta-analysis for smoking cessation. BMJ Open, 2016; 6(1).
  • 42. Sawangjit, R.; Khan, T.M.; Chaiyakunapruk, N. Effectiveness of pharmacy-based needle/syringe exchange programme for people who inject drugs: A systematic review and meta-analysis. Addiction, 2016; 112: 236-247.
  • 43. Sam, S.; Guérin, A.; Rieutord, A.; Belaiche, S.; Jean-François Bussières, J.F. Roles and impacts of the transplant pharmacist: A systematic review can. J Hosp.pharm.50.sam, Guérin, A, Rieutord,A., Belaiche S.,Jean-François Bussières, J.F. roles and impacts of the transplant pharmacist: A systematic review. Can. J.Hosp.pharm, 2018; 71: 324-337.
  • 44. Elyan, J.; Francis, S.-A.; Yardley, S. Understanding the Potential for Pharmacy Expertise in Palliative Care: The Value of Stakeholder Engagement in a Theoretically Driven Mapping Process for Research. Pharmacy, 2021; 9: 192.
  • 45. Newman, T.V.; San-Juan-Rodriguez, A.; Parekh, N.; Swart, E.C.; Klein-Fedyshin, M.; Shrank, W.H.; Hernandez, I. Impact of community pharmacists-led interventions in chronic disease management on clinical, utilization, and economics outcomes: An umbrella review. Res. soc. Adm.pharm, 2020; 16: 1155-1165.
  • 46. Tan, E.C.; Stewart, K.; Elliott, R.A.; George, J. Pharmacist services provided in general practice clinics: A systematic review and meta-analysis. Res. soc. Adm.pharm, 2014; 10: 608-622.
  • 47. Kirkdale, C.; Nebout, G.; Megerlin, F.; Thornley, T. Benefits of pharmacist-led flu vaccination services in community pharmacy. In Annales pharmaceutiques Francaise; Elsevier: Amsterdam, The Netherlands, 2017; 75: 3-8.
  • 48. Paudyal, V.; Fialová, D.; Henman, M.C.; Hazen, A.; Okuyan, B.; Lutters, M.; Cadogan, C.; Alves da Costa, F.; Galfrascoli, E.;pudritzY.M,pharmacists involvement in COVID-19 vaccination across Europe:A situational analysis of current practice and policy. Int. J.Clin. Pharm, 2021; 43: 1139-1148.
  • 49. Mereckienė J, Cotter S, Nicoll A, Lopalco P, Noori T, Weber JT, D'Ancona F, Lévy-Bruhl D, Dematte L, Giambi C, Valentiner-Branth P, Stankiewicz I, Appelgren E, O'Flanagan D, and the VENICE Project Gatekeepers Group. Seasonal influenza immunisation in Europe. Overview of recommendations and vaccination coverage for three seasons: pre-pandemic (2008/09), pandemic (2009/10) and post-pandemic (2010/11). Euro Surveill, 2014; 19(16): 20780.
  • 50. Howard, P. Antimicrobial Stewardship in Community Pharmacy—What Do Commissioners Need to Know?, 2015.
  • 51. Paudyal, V.; Fialová, D.; Henman, M.C.; Hazen, A.; Okuyan, B.; Lutters, M.; Cadogan, C.; Alves da Costa, F.; Galfrascoli, E.;pudritzY.M,pharmacists involvement in COVID-19 vaccination across Europe:A situational analysis of current practice and policy. Int. J.Clin. Pharm, 2021; 43: 1139-1148.
  • 52. Bragazzi, N.L.; Mansour, M.; Bonsignore, A.; Ciliberti, R. The Role of Hospital and Community Pharmacists in the Management of COVID-19: Towards an Expanded Definition of the Roles, Responsibilities,and Duties of the Pharmacist. Pharmacy, 2020; 8: 140.
  • 53. LEEM: Les Entreprises du Médicament. Santé 2030, une Analyse Prospective de L'innovation en Santé, 2021.
  • 54. Davies, L.E.; Spiers, G.; Kingston, A.; Todd, A.; Adamson, J.; Hanratty, B. Adverse Outcomes of Polypharmacy in Older People:Systematic Review of Reviews. J.Am.Med.Dir.Assoc, 2020; 21: 181-187.
  • 55. Khezrian, M.; McNeil, C.J.; Murray, A.; Myint, P.K. An overview of prevalence, determinants and health outcomes of polypharmacy. Ther. Adv. Drug Saf., 2020; 11: 2042098620933741.
  • 56. Ibrahim, A.S.H.; Barry, H.E.; Hughes, C.M. A systematic review of general practice-based pharmacists' services to optimize medicines Management in Older People with multimorbidity and Polypharmacy. Farm.pract, 2021; 38: 509-523.
  • 57. Beechinor, R.J.; Overberg, A.; Brown, C.S.; Cummins, S.; Mordino, J. Climate change is here: What will the profession of pharmacy do about it? Am. J. health Pharm, 2022; 79: 1393-1396.
  • 58. Roy, C. The pharmacist's role in climate change: A call to action. Can. Pharm. J./Rev. Pharm. Can., 2021; 154: 74–75.
  • 59. Morse, S.S.; Mazet, J.A.; Woolhouse, M.; Parrish, C.R.; Carroll, D.; Karesh, W.B.; Zambrana-Torrelio, C.; Lipkin, W.I.; Daszak, P. Prediction and prevention of the next pandemic zoonosis. Lancet, 2012; 380: 1956-1965.
  • 60. Carlson, C.J.; Albery, G.F.; Merow, C.; Trisos, C.H.; Zipfel, C.M.; Eskew, E.A.; Olival, K.J.; Ross, N.; Bansal, S. Climate change increases cross-species viral transmission risk. Nature, 2022; 607: 555-562.
  • 61. Clark, L.T.; Watkins, L.; Piña, I.L.; Elmer, M.; Akinboboye, O.; Gorham, M.; Jamerson, B.; McCullough, C.; Pierre, C.; Polis, A.B.; increasing diversity in clinical trials. Overcoming critical barriers. Curr. probl. Cardiol, 2019; 44: 148-172.